TELA — TELA Bio, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1561921 ·
Last close
$0.76
Market Cap
$34.44M
52W High
$1.50
52W Low
$0.50
ADV30
141,786
Next earnings
2026-11-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 18,959,000 | 12,308,000 | -7,290,000 | -9,302,000 | 49,494,000 | 22,664,000 | 74,070,000 |
| Jun 2026 | 19,291,000 | 13,943,000 | -9,283,000 | -11,262,000 | 59,738,000 | 30,424,000 | 75,604,000 |
| Mar 2026 | 19,059,000 | 12,520,000 | -10,526,000 | -12,273,000 | 69,891,000 | 39,541,000 | 75,092,000 |
| Dec 2025 | 20,869,000 | 13,755,000 | -6,648,000 | -9,041,000 | 81,418,000 | 50,845,000 | 75,105,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-34,113,000
Investing CF
$1,638,000
Financing CF
$25,478,000
CapEx
$-276,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.74
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-430,398,000
Inventory
$11,609,000
Receivables
$9,273,000
ST Investments
—
EBIT TTM
$-33,645,000
Pretax Income TTM
$-41,510,000
Interest Exp TTM
$7,865,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$78,178,000
EBITDA
$-32,725,000
Free Cash Flow
$-16,964,500
Enterprise Value
$70,693,864
Total Cash
$22,664,000
Total Debt
$56,299,000
Shares Out
45,188,230
Trailing EPS
$-0.74
Book Value
$-0.54
ROE
-616.6%
ROA
-38.0%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 80,275,000 | -33,755,000 | -38,831,000 | 81,418,000 | 75,105,000 | 6,313,000 | -28,219,000 |
| Dec 2024 | 69,300,000 | -41,695,000 | -37,841,000 | 86,570,000 | 58,112,000 | 28,458,000 | -41,595,000 |
| Dec 2023 | 58,453,000 | -44,075,000 | -46,664,000 | 78,048,000 | 59,167,000 | 18,881,000 | -40,857,000 |
| Dec 2022 | 41,418,000 | -39,007,000 | -44,296,000 | 67,855,000 | 53,550,000 | 14,305,000 | -40,748,000 |
TTM Snapshot
Revenues TTM
$79,908,000
NetIncome TTM
$-41,179,000
OpCashFlow TTM
—
Assets (Latest)
$59,738,000
Forward EPS
$-0.47
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IDXG | INTERPACE BIOSCIENCES, INC. | $33.24M | $6.00 | — |
| ADGM | Adagio Medical Holdings, Inc. | $36.65M | $1.65 | — |
| MYO | MYOMO, INC. | $36.85M | $0.92 | — |
| NXGL | NEXGEL, INC. | $37.04M | $3.80 | — |
| SRTS | Sensus Healthcare, Inc. | $37.20M | $2.26 | — |
News headlines (Yahoo Finance, 1h cache)
TELA Bio Inc (TELA) (Q3 2026) Earnings Call Highlights: Cost Cuts, Leora Clearance and a Reset ...
2026-11-11 11:05 · Yahoo
TELA Bio (TELA) Q3 2026 Earnings Call Transcript
2026-11-11 03:44 · Yahoo
TELA Bio, Inc. Q3 2026 Earnings Call Summary
2026-11-11 03:27 · Yahoo
TELA Bio, Inc. (TELA) Reports Q3 Loss, Beats Revenue Estimates
2026-11-10 21:10 · Yahoo
TELA Bio Reports Third Quarter 2026 Financial Results
2026-11-10 21:00 · Yahoo
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-11-06 21:05 · Yahoo
TELA Bio to Announce Third Quarter 2026 Financial Results
2026-10-27 20:05 · Yahoo
TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement
2026-10-05 12:00 · Yahoo
TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative
2026-08-31 11:00 · Yahoo
TELA Bio (TELA) Q2 2026 Earnings Call Transcript
2026-08-19 13:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.